{
  "meta": {
    "title": "Ecg_Arrhythmias_Part_1",
    "url": "https://brainandscalpel.vercel.app/ecg-arrhythmias-part-1-d28170b3.html",
    "scrapedAt": "2025-11-30T11:12:56.104Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Permanent pacemaker</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Implantable cardiac defibrillator</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man had a history of myocardial infarction 6 months ago. He had two episodes of syncope, and the ECG tracing during one such episode is given below. Coronary angiography showed a 99% LAD artery stenosis, and angioplasty was unsuccessful due to the tortuosity of the vessel. Echocardiography shows a dilated LV at 5.9 cm with an ejection fraction of 28%. Which is the most appropriate therapy?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202406196ce60f7b-c8e7-4ca4-a8d8-ed63465f8f03.png\"></span></p>",
      "unique_key": "DT1281167",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281167,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Implantable cardioverter-defibrillators (ICDs) </strong>are indicated for secondary prevention in patients with documented VT/VF not due to reversible causes; this patient's syncope with ECG evidence of ventricular arrhythmia after an MI qualifies him.</p>\n<p>The <strong>indications</strong> for an <strong>Implantable Cardioverter Defibrillator (ICD)</strong> include:</p>\n<ul>\n<li>Patients with a <strong>history of sustained VT/VF</strong> not due to acute MI or any reversible cause.</li>\n<li><strong>History of previous MI and EF &lt; 35% </strong>for NYHA Class II or III, EF &lt; 30% for Class 1.</li>\n<li><strong>Familial </strong>or inherited condition with predisposition for <strong>VT/VF.</strong></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Amiodarone (Option A): </strong>Antiarrhythmic therapy may suppress VT but has not demonstrated a mortality benefit for secondary prevention compared to ICD implantation.</p>\n<p><strong>Atenolol (Option B):</strong> Beta-blockers improve overall survival post-MI but are insufficient alone to prevent fatal ventricular arrhythmias in high-risk, low-EF patients.</p>\n<p><strong>Permanent pacemaker (Option C):</strong> Pacemakers address bradyarrhythmias and conduction blocks, not malignant ventricular tachyarrhythmias, and do not prevent sudden cardiac death.</p>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyrotoxicosis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchial Asthma</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Ischaemic heart disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old man presents with a regular narrow complex tachycardia of 160 bpm, suggestive of paroxysmal supraventricular tachycardia. Which of the following is a contraindication to the use of the first-line medication in this condition?</span></p>",
      "unique_key": "DT1281168",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281168,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Adenosine</strong> is the first-line agent used in <strong>paroxysmal supraventricular tachycardia (PSVT),</strong> but it can produce profound bronchospasm, especially in asthmatics, and it is contraindicated.</p>\n<ul>\n<li>Adenosine is the first-line agent for acute termination of PSVT by <strong>transiently blocking AV nodal conduction</strong>. Its ultra-short half-life requires <strong>rapid IV </strong>bolus administration for clinical effect.</li>\n<li>In patients with known or suspected bronchoconstrictive lung disease, adenosine can provoke severe <strong>bronchospasm via activation of pulmonary A<sub>2</sub>B receptors</strong>, risking life-threatening respiratory compromise.</li>\n<li>Major guidelines list reactive airway disease (asthma, COPD) as an absolute contraindication to adenosine use, making alternative therapies (e.g., verapamil or beta-blockers) preferable in this setting.</li>\n</ul>\n<p><strong>Contraindications to adenosine:</strong></p>\n<ul>\n<li><strong>Hypersensitivity to adenosine</strong> or any component of the formulation</li>\n<li><strong>Second- or third-degree AV block</strong></li>\n<li><strong>Sick sinus syndrome</strong>, or symptomatic bradycardia (except in patients with a functioning artificial pacemaker), known or suspected bronchoconstrictive or bronchospastic lung disease</li>\n<li><strong>Atrioventricular re-entrant tachycardia (AVRT)</strong> or <strong>pre-excitation AF</strong> in <strong>WPW </strong>syndrome.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Thyrotoxicosis (Option A): </strong>Adenosine is not contraindicated in hyperthyroid patients and can be used safely to terminate PSVT.</p>\n<p><strong>Ventricular tachycardia (Option B):</strong> While adenosine is ineffective for VT and thus not the drug of choice, VT is not an absolute contraindication; its use simply lacks therapeutic benefit.</p>\n<p><strong>Ischaemic heart disease (Option D): </strong>Adenosine may cause transient coronary steal, but it is not absolutely contraindicated in stable IHD and remains an option with caution.</p>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial flutter</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrioventricular re-entry tachycardia (AVRT)</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrioventricular nodal re-entry tachycardia (AVNRT)</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old man attends the ER because of palpitations. Before they could do an ECG, his palpitations self-terminated. The ECG tracing at sinus rhythm is shown below. What is the likely mechanism of the patient's tachycardia?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202406198187f439-b462-4605-9fcb-1f91867c4c68.jpg\"></span></p>",
      "unique_key": "DT1281169",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281169,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The <strong>PR interval is short</strong> (&lt;3 small squares or &lt;120 ms) with the presence of <strong>'Delta wave'</strong> and <strong>prolonged QRS</strong>, suggesting <strong>Wolff Parkinson white syndrome.</strong></li>\n<li>It is associated with an <strong>accessory pathway (bundle of Kent)</strong>, resulting in <strong>pre-excitation of ventricles</strong> and predisposing to <strong>AVRT</strong>. Less commonly, WPW can predispose to <strong>Atrioventricular nodal re-entrant tachycardia (AVNRT) </strong>also.</li>\n<li>Patients often experience abrupt-onset, regular narrow-complex tachycardia (orthodromic AVRT) and may be at risk for atrial fibrillation with rapid ventricular response; definitive treatment is radiofrequency catheter ablation of the accessory pathway.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Atrial flutter (Option A): </strong>Involves a right-atrial macro-reentrant circuit producing saw-tooth flutter waves without pre-excitation or delta waves.</p>\n<p><strong>Atrioventricular nodal re-entry tachycardia (AVNRT) (Option C):</strong> Requires dual AV nodal pathways only and shows normal PR interval and QRS in sinus rhythm.</p>\n<p><strong>Ventricular tachycardia (Option D):</strong> Originates in ventricular myocardium, manifests as wide-complex tachycardia, and is unrelated to accessory-pathway reentry.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Sotalol</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Flecainide</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old man with a history of previous myocardial infarction presents with palpitations. The ECG tracing is shown below. His BP was 130/80mmHg. The first-line treatment should be:<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202406192c3acd2e-24e2-4da9-b883-7c122e3f1dc4.jpg\"></span></p>",
      "unique_key": "DT1281170",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281170,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The likely diagnosis is <strong>ventricular tachycardia,</strong>in view of the broad complex tachycardia in the setting of a previous MI and a structurally abnormal heart.</li>\n<li><strong>Amiodarone is the best pharmacological agent as a first line.</strong></li>\n<li><strong>Lignocaine</strong> and <strong>flecainide</strong> <strong>(Option B) </strong>can also be used, but are not considered the treatment of choice.</li>\n<li>If the patient has hemodynamic instability (hypotension/angina/impaired consciousness/heart failure), DC cardioversion is the initial management of choice.</li>\n<li>Although a Class III agent, <strong>sotalol (Option A)</strong> carries a higher risk of <strong>torsades de pointes</strong> and is less preferred acutely in structural heart disease.</li>\n<li><strong>Verapamil</strong> (Option C) is a <strong>calcium-channel blocker ineffective for VT </strong>and may worsen hypotension without addressing the ventricular arrhythmia.</li>\n</ul>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old asymptomatic woman, as part of her routine health checkup, underwent ECG testing, which is shown below. Which of the following drugs should be started in her?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/202406196dc1c23d-2f9f-4a5f-b5f2-374598c64b57.jpg\"></span></p>",
      "unique_key": "DT1281171",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281171,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>On the ECG, the interval from the start of the Q wave to the end of the T wave spans five large squares. Since each large square represents 0.2 seconds, the measured QT interval is one full second.</li>\n<li>To account for heart rate, we calculate the <strong>corrected QT interval or QTc.</strong></li>\n<li><strong>QTc = QT/square root of RR interval.</strong> Here, the RR interval is 9 large squares, which is 1.8 seconds.</li>\n<li>So the corrected QT will be 1/square root of 1.8 = 0.74, well above the normal upper limit of 0.42 seconds in women.</li>\n<li>Such a <strong>markedly prolonged QTc</strong>, even in an asymptomatic patient, points to <strong>congenital long QT syndrome.</strong> This inherited ion-channel disorder delays ventricular repolarisation and <strong>predisposes to torsades de pointes and sudden cardiac death.</strong></li>\n<li><strong>Nonselective beta blockers like propranolol </strong>blunt sympathetic stimulation of the heart, reduce dispersion of repolarisation, lower the QTc interval, and have been shown to<strong> prevent life-threatening arrhythmias in long QT syndrome.</strong></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Digoxin (Option B): </strong>Does not shorten the QT interval and may exacerbate repolarisation delay, increasing arrhythmia risk.</p>\n<p><strong>Amiodarone (Option C): </strong>Further prolongs the QT interval, heightening torsades risk; contraindicated in congenital long QT syndrome.</p>\n<p><strong>Verapamil (Option D): </strong>Lacks efficacy in correcting repolarisation defects and offers no protection against sudden ventricular arrhythmias.</p>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Pericarditis</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Turner's syndrome</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Dextrocardia</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Aortic stenosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely diagnosis for the patient with the ECG shown in the image?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240619395fde63-8b8c-4e10-a23e-b73d301842d5.jpg\"></span></p>",
      "unique_key": "DT1281172",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281172,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>ECG features of dextrocardia seen here include<strong> global negativity in lead I </strong>(inverted P wave, QRS, and T wave), <strong>absent R-wave progression</strong> across the precordial leads, and a<strong> dominant R wave in V1.</strong></p>\n<p><strong>In dextrocardia, the heart is oriented toward the right hemithorax</strong>, causing <strong>limb-lead polarity reversal and mirror-image chest-lead patterns</strong> as the depolarisation vector shifts direction.</p>\n<p><strong>ECG findings in dextrocardia</strong></p>\n<ul>\n<li>Right axis deviation</li>\n<li>Positive QRS complexes</li>\n<li>Global negativity in lead 1 <strong>(inverted P wave, negative QRS and inverted T wave)</strong></li>\n<li>Absent R wave progression in chest leads.</li>\n</ul>\n<p><strong>A dominant R in lead V1 on the ECG is associated with:</strong></p>\n<ul>\n<li>Primary pulmonary HT</li>\n<li>Right bundle branch block (RBBB) (including Ebstein's anomaly)</li>\n<li>Wolf-Parkinson-White syndrome (Type A)</li>\n<li>Dextrocardia</li>\n<li>Posterior MI</li>\n<li>Duchenne muscular dystrophy</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Pericarditis (Option A): </strong>Characterised by diffuse ST-segment elevation and PR depression, not limb-lead inversions or loss of R-wave progression.</p>\n<p><strong>Turner's syndrome (Option B): </strong>A chromosomal condition without a specific ECG pattern; any associated cardiac defects do not produce this ECG appearance.</p>\n<p><strong>Aortic stenosis (Option D): </strong>Leads to left ventricular hypertrophy patterns (e.g., high-voltage QRS), not inversion of lead I or absent precordial R waves.</p>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old patient with rheumatic mitral stenosis has a history of palpitations and irregular heartbeat. She presented unwell with fast Atrial Fibrillation and was DC cardioverted successfully. Which of the following medications is most effective for the maintenance of sinus rhythm?</span></p>",
      "unique_key": "DT1281173",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281173,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation for answer:</strong></p>\n<ul>\n<li>Amiodarone is most effective for the maintenance of sinus rhythm.</li>\n<li>Beta-blockers and non-dihydropyridine calcium channel blockers are used to control the ventricular rate in patients with Atrial fibrillation.</li>\n<li>In patients with structural heart disease such as rheumatic mitral stenosis, amiodarone's efficacy in maintaining sinus rhythm after cardioversion exceeds that of other antiarrhythmics.</li>\n<li>Long-term use requires monitoring for thyroid, pulmonary, and hepatic toxicity, but its rhythm-control benefits in high-risk valvular AF justify its selection.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Digoxin (Option A): </strong>Primarily used for rate control via AV-nodal slowing; it does not effectively maintain sinus rhythm after cardioversion.</p>\n<p><strong>Atenolol (Option C):</strong> A beta-blocker effective at controlling ventricular rate but inferior to amiodarone for rhythm maintenance.</p>\n<p><strong>Diltiazem (Option D):</strong> A non-dihydropyridine calcium-channel blocker useful for rate control in AF but not recommended for long-term maintenance of sinus rhythm.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Atenolol</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Flecainide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old woman with no significant medical history presents with new-onset palpitations. Her ECG reveals atrial fibrillation. Which one of the following drugs is most likely to restore sinus rhythm?</span></p>",
      "unique_key": "DT1281174",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281174,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>Flecainide is a class I C antiarrhythmic drug that blocks fast sodium channels, suppresses atrial excitability, promotes restoration of sinus rhythm and prevents the recurrence of AF.</li>\n<li>Flecainide may prolong the QT interval.</li>\n<li>It is particularly effective in patients without structural heart disease, offering high conversion rates and maintenance of sinus rhythm.</li>\n<li>In patients with underlying ischemic or structural heart disease, flecainide increases proarrhythmic risk and mortality, so its use is contraindicated in that setting.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Diltiazem (Option A): </strong>A non-dihydropyridine calcium-channel blocker used for rate control in atrial fibrillation but not for rhythm conversion.</p>\n<p><strong>Digoxin (Option B):</strong> Primarily slows AV nodal conduction for ventricular rate control, with minimal efficacy in converting atrial fibrillation to sinus rhythm.</p>\n<p><strong>Atenolol (Option C):</strong> A beta-blocker effective at controlling ventricular rate but cannot restore sinus rhythm in atrial fibrillation.</p>",
      "correct_choice_id": 74,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">QRS of 180 ms</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Left bundle branch block and left axis deviation</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">P wave for every QRS complex</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">History of atrial fibrillation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old lady has palpitations. Her ECG shows a broad complex tachycardia. Which of these features suggests that the tachycardia is more likely to be of ventricular origin?</span></p>",
      "unique_key": "DT1281175",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281175,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>A QRS duration of 180 ms far exceeds the normal conduction time and strongly indicates ventricular tachycardia</strong>, as impulses travel slowly through ventricular muscle rather than the His-Purkinje system.</p>\n<p>VT typically arises from reentrant circuits in diseased ventricular myocardium, producing broad, abnormal QRS complexes reflective of slow, cell-to-cell conduction.</p>\n<p>Early recognition of a very wide QRS is a key step in VT algorithms and guides urgent management.</p>\n<p><strong>Features that favour VT:</strong></p>\n<ul>\n<li>QRS of &gt; 140ms</li>\n<li>Dissociated P waves, history of ischaemic heart disease</li>\n<li>right bundle branch block with left axis deviation</li>\n<li>HR &gt; 170 beats per minute</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Left bundle branch block and left axis deviation (Option B):</strong> These findings can occur in supraventricular tachycardia with aberrant conduction and lack the diagnostic specificity of extreme QRS widening.</p>\n<p><strong>P wave for every QRS complex (Option C):</strong> One P wave preceding each QRS implies atrioventricular association, favouring a supraventricular origin rather than VT.</p>\n<p><strong>History of atrial fibrillation (Option D):</strong> A prior history of AF does not determine the mechanism of a new broad-complex tachycardia and is not an ECG feature that identifies VT.</p>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">First-degree heart block</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Wenckebach block</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">2:1 Mobitz type II heart block</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Left bundle branch block</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man has had a myocardial infarction. His pulse rate is 45/min, and he is feeling lightheaded. Blood pressure is 90/65 mm Hg. In which one of the following conditions is temporary pacing indicated even when symptoms are absent?</span></p>",
      "unique_key": "DT1281176",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281176,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>2:1 Mobitz type II heart block</strong></p>\n<ul>\n<li><strong>2:1 Mobitz type II </strong>represents a <strong>high-degree AV block below the AV node</strong>, often within the His-Purkinje system, which <strong>can abruptly progress to complete heart block and asystole even in the absence of symptoms.</strong></li>\n<li>With <strong>ventricular rates frequently below 40 beats per minute</strong>, patients are at risk for <strong>syncope or severe hypotension,</strong> and <strong>prophylactic pacing prevents hemodynamic collapse.</strong></li>\n<li>Current pacing guidelines recommend <strong>temporary (and usually permanent) pacing for asymptomatic patients with second-degree Mobitz type II block</strong> post-MI to avert sudden progression to complete AV block.</li>\n</ul>\n<p><strong>Asymptomatic patients</strong> with <strong>Wenckebach (Mobitz type I) (Option B) </strong>AV block generally <strong>do not require specific therapy</strong>. Management should focus on identifying and treating any reversible causes, such as myocardial ischemia or medication effects.</p>\n<p><strong>Symptomatic patients</strong> with any degree of AV block should be treated urgently with <strong>atropine</strong> (initial dose 0.5 mg given intravenously) or <strong>temporary pacing </strong>(transcutaneous or transvenous).</p>\n<ul>\n<li><strong>Indications for permanent pacing:</strong>\n<ul>\n<li><strong>Symptomatic</strong>Brady arrhythmias with <strong>any degree</strong> of AV block</li>\n<li><strong>Asymptomatic high-degree </strong>AV block (second-degree <strong>Mobitz type II or third-</strong>degree heart block) with slow ventricular rates (less than 40 beats/min).</li>\n<li>Patients with presumed cardiac syncope with normal heart rates and rhythm but bifascicular or trifascicular block on ECG</li>\n</ul>\n</li>\n</ul>\n<p><strong>First-degree heart block (Option A): </strong>Characterised by PR prolongation only, rarely progresses, and does not require pacing.</p>\n<p><strong>Left bundle branch block (Option D):</strong> Conduction delay confined to the ventricles. Without an AV block, pacing is not indicated.</p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin is preferred over novel oral anticoagulants (NOACs) for stroke prevention in patients with AF at high risk of embolic stroke</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">NOACs are contraindicated in patients with prosthetic mechanical heart valves</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Warfarin is preferred over NOACs in patients with AF and severe mitral stenosis</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">After cardiac surgery, long-term anticoagulation should be considered in patients with post-operative AF at higher risk of stroke</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not true regarding the use of anticoagulation in Atrial fibrillation?</span></p>",
      "unique_key": "DT1281177",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281177,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Current guidelines favour <strong>NOACs over warfarin</strong> for <strong>stroke prevention in nonvalvular atrial fibrillation</strong> due to superior efficacy, lower major bleeding rates, fewer drug-food interactions, and no routine monitoring requirement.</p>\n<p><strong>NOACs</strong> include <strong>direct thrombin inhibitors (Dabigatran, Argatroban)</strong> and Factor <strong>Xa inhibitors (Apixaban, Rivaroxaban, Edoxaban)</strong></p>\n<p><strong>Warfarin's </strong>use is now limited to specific <strong>\"valvular\" AF populations</strong>, namely those with <strong>mechanical prosthetic valves or moderate-to-severe mitral stenosis</strong>. It is preferred over NOACs. <strong>(Option C) </strong></p>\n<p>Clinical trials showed increased thrombosis and bleeding when NOACs were used in mechanical valves, hence they are contraindicated. <strong>(Option A) </strong></p>\n<p><strong>New-onset AF after cardiac surgery carries elevated stroke risk in high CHA<sub>2</sub>DS<sub>2</sub>-VASc patients</strong>, and <strong>prolonged anticoagulation is recommended </strong>once reversible factors are addressed. <strong>(Option D)</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250920add92646-cdb7-4825-a86e-c457f8c6b3a8.png\">",
      "correct_choice_id": 101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral amiodarone</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Procainamide</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiofrequency ablation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 21-year-old woman has a history of palpitations and lightheadedness. ECG shows a short PR interval and inferior Q waves with prolonged QRS duration. Her symptoms improve with atenolol 25 mg/day, but she has had two short episodes of similar symptoms in the previous 24 hours. What is the long-term management of choice?</span></p>",
      "unique_key": "DT1281178",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281178,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The ECG demonstrates a <strong>short PR interval and delta wave</strong>, indicating ventricular pre-excitation via an accessory pathway. The diagnosis is<strong> Wolff-Parkinson-White </strong>syndrome, and the patient is experiencing <strong>atrioventricular re-entry tachycardia (AVRT)</strong>, which is not adequately controlled by medical therapy. She should be referred to a cardiac physiologist for <strong>radiofrequency ablation of the accessory pathway. </strong></li>\n<li>Long-term studies report &gt; 95% success with low complication rates, and ablation removes the need for chronic antiarrhythmic drugs and their potential toxicities.</li>\n<li><strong>Procainamide</strong> <strong>(Option C)</strong> is used to terminate acute attacks of AVRT due to WPW syndrome.</li>\n<li>Drugs like <strong>beta blockers, verapamil</strong> and <strong>adenosine</strong> <strong>(Option A)</strong> that block AV nodal conduction are contraindicated in AVRT due to WPW syndrome.</li>\n<li><strong>Amiodarone (Option B</strong>) is associated with significant long-term toxicity and inferior efficacy and is not preferred when ablation is available.</li>\n</ul>",
      "correct_choice_id": 114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial fibrillation</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Paroxysmal supraventricular tachycardia</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Multifocal atrial tachycardia</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Atrial flutter</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old male with acute exacerbation of COPD presented with worsening palpitations. The ECG tracing is given below. What is the likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/2024061967726c58-53b7-4502-84f7-9a0ca1207834.jpg\"></span></p>",
      "unique_key": "DT1281179",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281179,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Multifocal Atrial Tachycardia (MAT)</strong> is a rapid, irregular atrial rhythm arising from multiple ectopic foci within the atria.</li>\n<li>Usually seen in patients with advanced respiratory failure, with increased risk in those treated with beta agonists and theophyllines.</li>\n<li>Hypoxia, hypercapnia, and adrenergic stimulation in COPD trigger ectopic atrial activity, creating variable PR intervals and RR intervals on the ECG.</li>\n</ul>\n<p><strong>Multifocal atrial tachycardia - criteria</strong></p>\n<ul>\n<li>Heart rate &gt; 100 bpm (usually 100-150 bpm; may be as high as 250 bpm).</li>\n<li>Irregularly irregular rhythm with varying PP, PR and RR intervals.</li>\n<li>At least 3 distinct P-wave morphologies in the same lead.</li>\n<li>Isoelectric baseline between P-waves (i.e. no flutter waves).</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Atrial fibrillation (Option A): </strong>Characterised by absent discrete P waves and a chaotic baseline, not multiple distinct P-wave morphologies.</p>\n<p><strong>Paroxysmal supraventricular tachycardia (Option B): </strong>Typically a regular tachycardia with sudden onset and termination, without the irregular P-wave variation of MAT.</p>\n<p><strong>Atrial flutter (Option D): </strong>Shows uniform \"sawtooth\" flutter waves at ~300 bpm and often a regular ventricular response, lacking the polymorphic P waves of MAT.</p>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease the sensitivity of the conduction bundle to electrolytes</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Altering Purkinje fibre response</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Blocking an accessory pathway</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Blocking AV node conduction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old student presents with palpitations, and the ECG tracing is given below. A drug was administered as an intravenous bolus, which has led to the achievement of sinus rhythm. What is the likely mechanism of action of the drug?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V2NEETPGMCQ/20240619d2266f3a-4b60-4d46-b509-d9b82a6db0cd.jpg\"></span></p>",
      "unique_key": "DT1281180",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281180,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li>The given ECG tracing is that of <strong>Paroxysmal supraventricular tachycardia.</strong></li>\n<li><strong>Supraventricular tachycardia (SVT)</strong> refers to any tachydysrhythmia arising from above the level of the <strong>Bundle of His</strong>, and encompasses regular atrial, irregular atrial, and regular atrioventricular tachycardias.</li>\n<li>The term <strong>paroxysmal SVT</strong> is often used synonymously with <strong>AV nodal re-entry tachycardia (AVNRT)</strong>, a form of SVT.<u> </u></li>\n</ul>\n<p><strong>ECG features of PSVT: </strong></p>\n<ul>\n<li>Regular tachycardia ~ 150 - 200 bpm</li>\n<li><strong>Narrow QRS complexes (&lt; 120ms)</strong> unless there is co-existing bundle branch block, accessory pathway</li>\n<li><strong>P waves</strong> may not be readily identifiable. If visible, exhibit retrograde conduction with <strong>P-wave inversion in leads II, III, and aVF.</strong> They may be buried within, visible after, or very rarely visible before the QRS complex.</li>\n<li><strong>Adenosine is the pharmacological treatment of choice for PSVT</strong> and works by slowing atrioventricular (AV) conduction, hence breaking the re-entry circuit, which can be an AVNRT or AVRT in supraventricular tachycardia.</li>\n</ul>",
      "correct_choice_id": 134,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Lifelong amiodarone</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Implantable cardiac defibrillator</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Procainamide</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Permanent pacemaker</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old man had a ventricular fibrillation cardiac arrest whilst at a railway station. He was successfully resuscitated by a co-passenger. Further evaluation at the hospital, including coronary angiography, showed no stenotic lesions in the coronary arteries. Which is the most appropriate step for long-term management?</span></p>",
      "unique_key": "DT1281181",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281181,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<ul>\n<li><strong>Implantable cardioverter-defibrillators (ICDs) </strong>are indicated for secondary prevention in survivors of cardiac arrest due to ventricular fibrillation when no reversible cause is found, as they automatically detect and terminate malignant arrhythmias.</li>\n<li>A cardiac electrophysiological study would be necessary to help confirm whether this patient has inducible ventricular tachycardia, and ablation of the pathways if so.</li>\n<li>However, in a young patient without significant coronary artery disease amenable to revascularisation, implantation of an ICD is indicated to prevent recurrent life-threatening ventricular arrhythmias.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Lifelong amiodarone (Option A): </strong>Offers antiarrhythmic protection but lacks the proven survival advantage of ICDs in secondary prevention of sudden cardiac death.</p>\n<p><strong>Procainamide (Option C): </strong>Useful for acute termination of ventricular arrhythmias but not intended for long-term prevention of recurrent VF.</p>\n<p><strong>Permanent pacemaker (Option D): </strong>Treats bradyarrhythmias and heart block but cannot terminate ventricular tachyarrhythmias, making it inappropriate for VF prevention.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Procainamide</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Flecainide</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Quinidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-arrhythmic drugs is associated with drug-induced lupus erythematosus?</span></p>",
      "unique_key": "DT1281182",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281182,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Drug-induced lupus occurs due to the triggering of autoimmunity by the culprit medications, resulting in clinical features like fever, joint pain, rashes, serosal involvement, etc.</p>\n<p><strong>The common drugs implicated in drug-induced SLE include:</strong></p>\n<ul>\n<li>Procainamide</li>\n<li>Hydralazine</li>\n<li>INH</li>\n<li>Sulfasalazine</li>\n<li>Anti-TNF drugs</li>\n</ul>\n<p>Drug-induced lupus is characterised by <strong>anti-histone antibodies.</strong></p>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Amiodarone (Option A): </strong>Not implicated in lupus. Its major toxicities include pulmonary fibrosis, thyroid dysfunction, and hepatic injury.</p>\n<p><strong>Flecainide (Option C): </strong>Does not trigger autoimmune lupus. Adverse effects are primarily proarrhythmia and central nervous system symptoms.</p>\n<p><strong>Quinidine (Option D): </strong>Not associated with lupus. Side effects include cinchonism, QT prolongation, and thrombocytopenia.</p>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Magnesium</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Procainamide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 47-year-old man presents with broad complex tachycardia. He has a BP of 102/70 and a pulse rate of 176/min. The doctor on duty is considering the administration of an antiarrhythmic. Which one of the following medications is contraindicated in this patient?</span></p>",
      "unique_key": "DT1281183",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281183,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation: </strong></p>\n<ul>\n<li>In stable <strong>monomorphic ventricular tachycardia</strong>, <strong>verapamil is contraindicated</strong> because its <strong>potent AV-nodal blockade and negative inotropic effect</strong> can precipitate severe hypotension and cardiovascular collapse when the ventricles are driving the rhythm.</li>\n<li>Ventricular tachycardia originates from reentrant circuits or focal automaticity in the ventricular myocardium; calcium-channel blockers do not interrupt these circuits and instead reduce contractile force, worsening hemodynamics.</li>\n<li>Clinical guidelines recommend <strong>intravenous amiodarone or procainamide</strong> for stable VT, explicitly advising against <strong>verapamil unless the rhythm is definitively supraventricular with aberrancy.</strong></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Magnesium (Option A): </strong>Not contraindicated; useful especially in torsades de pointes or to stabilise myocardium in certain polymorphic VTs.</p>\n<p><strong>Amiodarone (Option B): </strong>First-line antiarrhythmic for stable VT due to its broad electrophysiologic effects and favourable safety profile in structural heart disease.</p>\n<p><strong>Procainamide (Option D): </strong>Effective in stable VT by blocking sodium channels and delaying conduction in abnormal ventricular tissue; recommended when amiodarone is unavailable or contraindicated.</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Wolff Parkinson White syndrome</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Brugada syndrome</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Lev-Lenegre disease</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Lown-Ganong-Levine syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 20-year-old male was evaluated for episodes of palpitations and syncopal attacks. The ECG tracing shows the following findings - normal P wave morphology, short PR interval, normal QRS duration and morphology. What is the likely diagnosis in this patient?</span></p>",
      "unique_key": "DT1281184",
      "question_audio": null,
      "question_video": null,
      "map_id": 1281184,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p><strong>Lown-Ganong-Levine syndrome</strong></p>\n<ul>\n<li>Pre-excitation syndrome, like WPW characterised by an accessory pathway called James fibres</li>\n<li>May present with palpitations, recurrent syncopal attacks. A family history of sudden cardiac death may be present in familial causes.</li>\n<li>Unlike WPW syndrome, delta waves are absent, and QRS duration is normal. (delta wave present and QRS prolonged in WPW syndrome)</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250920e99be1ae-d615-41e4-8104-093873f8a2cc.png\">\n<p><strong>Brugada syndrome (Option B)</strong> is a sodium channel (SCN5A) defect characterised by ST elevation in precordial leads and may predispose the individual to VT and sudden cardiac death.</p>\n<p><strong>Lev's Lenegre's disease</strong> <strong>(Option C)</strong> refers to acquired fibrous degeneration of the left and right bundle branches, eventually leading to permanent complete atrioventricular (AV) dissociation.</p>",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}